DZ2544A1 - Formes posologiques de sertraline et procédé pour leur préparation. - Google Patents

Formes posologiques de sertraline et procédé pour leur préparation.

Info

Publication number: DZ2544A1
Authority: DZ; Algeria
Prior art keywords: sertraline; preparation; dosage forms; dosage; forms
Prior art date: 1997-07-01

Application number

DZ980154A

Other languages

English (en)

Inventor

William John Curatolo

Ravi Mysore Shanker

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-06-30

Publication date

2003-02-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2544(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-30 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2003-02-08 Application granted granted Critical

2003-02-08 Publication of DZ2544A1 publication Critical patent/DZ2544A1/fr

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Hematology (AREA)
Obesity (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

DZ980154A 1997-07-01 1998-06-30 Formes posologiques de sertraline et procédé pour leur préparation. DZ2544A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5140197P	1997-07-01	1997-07-01

Publications (1)

Publication Number	Publication Date
DZ2544A1 true DZ2544A1 (fr)	2003-02-08

Family

ID=21971076

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ980154A DZ2544A1 (fr)	1997-07-01	1998-06-30	Formes posologiques de sertraline et procédé pour leur préparation.

Country Status (40)

Country	Link
EP (1)	EP0980241B1 (fr)
JP (1)	JP3585245B2 (fr)
KR (1)	KR100371730B1 (fr)
CN (1)	CN1261792A (fr)
AP (1)	AP945A (fr)
AR (1)	AR015916A1 (fr)
AT (1)	ATE256457T1 (fr)
AU (1)	AU724635B2 (fr)
BG (1)	BG103917A (fr)
BR (1)	BR9809712A (fr)
CA (1)	CA2290973C (fr)
CO (1)	CO4940405A1 (fr)
DE (1)	DE69820608T2 (fr)
DK (1)	DK0980241T3 (fr)
DZ (1)	DZ2544A1 (fr)
EA (1)	EA001905B1 (fr)
ES (1)	ES2210760T3 (fr)
GT (1)	GT199800090A (fr)
HR (1)	HRP980378B1 (fr)
HU (1)	HUP0002250A3 (fr)
ID (1)	ID24673A (fr)
IL (1)	IL133075A0 (fr)
IS (1)	IS5266A (fr)
MA (1)	MA24586A1 (fr)
MY (1)	MY119728A (fr)
NO (1)	NO996492L (fr)
NZ (1)	NZ501252A (fr)
OA (1)	OA11246A (fr)
PA (1)	PA8454001A1 (fr)
PE (1)	PE97299A1 (fr)
PL (1)	PL337807A1 (fr)
PT (1)	PT980241E (fr)
SK (1)	SK282914B6 (fr)
TN (1)	TNSN98123A1 (fr)
TR (1)	TR199903282T2 (fr)
TW (1)	TW382597B (fr)
UA (1)	UA68350C2 (fr)
UY (1)	UY25070A1 (fr)
WO (1)	WO1999001113A1 (fr)
ZA (1)	ZA985709B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA72743C2 (en) *	1998-10-13	2005-04-15	Pfizer Prod Inc	Essentially nonaqueous liquid pharmaceutical concentrate composition containing sertraline, method of using this concentrate, method for treatment
US6727283B2 (en)	1998-10-13	2004-04-27	Pfizer Inc.	Sertraline oral concentrate
EP1671628B1 (fr)	1999-09-03	2012-10-03	APBI Holdings, LLC	Inhibiteurs de réabsorption de sérotonine à action rapide pour le traitement des dysfonctions sexuelles
CA2420535A1 (fr)	2000-08-30	2002-03-07	Mary Tanya Am Ende	Formulations a liberation prolongee pour les secretagogues de l'hormone de croissance
EP1375659A1 (fr) *	2002-06-18	2004-01-02	Laboratorio di Diagnostica Moleculare	Mélanges concentrés dans des capsules solubles pour la préparation facilitée de solutions chimiques ou biologiques
AU2003291667A1 (en) *	2002-10-31	2004-06-07	Alza Corporation	Pharmaceutical formulation providing an increased bioavailability of hydrophobic drugs
WO2016020936A2 (fr) *	2014-07-21	2016-02-11	Patel Jayendrakumar Dasharathlal	Nouvelle forme posologique pharmaceutique orale de rétention gastrique
CN108014087A (zh) *	2017-12-27	2018-05-11	江苏联环药业股份有限公司	一种盐酸舍曲林胶囊的制备方法
GB2630572A (en)	2023-05-29	2024-12-04	Novumgen Ltd	An orally disintegrating tablet of sertraline and its process of preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0782445T3 (da) *	1994-09-19	2002-05-06	Bristol Myers Squibb Pharma Co	Kombination af en opioidantagonist og en selektiv serotoningenoptagelsesinhibitor til behandling af alkoholisme og alkoholafhængighed
ATE235237T1 (de) *	1995-07-17	2003-04-15	Pfizer	Sertralin zur behandlung von post-myocard-infarkt-patienten

1998
- 1998-06-16 TR TR1999/03282T patent/TR199903282T2/xx unknown
- 1998-06-16 IL IL13307598A patent/IL133075A0/xx unknown
- 1998-06-16 AT AT98923021T patent/ATE256457T1/de not_active IP Right Cessation
- 1998-06-16 DK DK98923021T patent/DK0980241T3/da active
- 1998-06-16 HU HU0002250A patent/HUP0002250A3/hu unknown
- 1998-06-16 BR BR9809712-1A patent/BR9809712A/pt not_active Application Discontinuation
- 1998-06-16 NZ NZ501252A patent/NZ501252A/en unknown
- 1998-06-16 PL PL98337807A patent/PL337807A1/xx unknown
- 1998-06-16 PT PT98923021T patent/PT980241E/pt unknown
- 1998-06-16 CA CA002290973A patent/CA2290973C/fr not_active Expired - Fee Related
- 1998-06-16 UA UA99116393A patent/UA68350C2/uk unknown
- 1998-06-16 EP EP98923021A patent/EP0980241B1/fr not_active Expired - Lifetime
- 1998-06-16 AU AU75450/98A patent/AU724635B2/en not_active Ceased
- 1998-06-16 SK SK1805-99A patent/SK282914B6/sk unknown
- 1998-06-16 EA EA199900963A patent/EA001905B1/ru not_active IP Right Cessation
- 1998-06-16 CN CN98806765A patent/CN1261792A/zh active Pending
- 1998-06-16 ID IDW991697A patent/ID24673A/id unknown
- 1998-06-16 ES ES98923021T patent/ES2210760T3/es not_active Expired - Lifetime
- 1998-06-16 JP JP50677699A patent/JP3585245B2/ja not_active Expired - Fee Related
- 1998-06-16 WO PCT/IB1998/000936 patent/WO1999001113A1/fr not_active Ceased
- 1998-06-16 KR KR10-1999-7011596A patent/KR100371730B1/ko not_active Expired - Fee Related
- 1998-06-16 DE DE69820608T patent/DE69820608T2/de not_active Expired - Fee Related
- 1998-06-19 PA PA19988454001A patent/PA8454001A1/es unknown
- 1998-06-25 TW TW087110254A patent/TW382597B/zh not_active IP Right Cessation
- 1998-06-25 AP APAP/P/1998/001279A patent/AP945A/en active
- 1998-06-26 PE PE1998000575A patent/PE97299A1/es not_active Application Discontinuation
- 1998-06-29 AR ARP980103145A patent/AR015916A1/es not_active Application Discontinuation
- 1998-06-29 MY MYPI98002949A patent/MY119728A/en unknown
- 1998-06-29 GT GT199800090A patent/GT199800090A/es unknown
- 1998-06-29 UY UY25070A patent/UY25070A1/es not_active IP Right Cessation
- 1998-06-30 ZA ZA9805709A patent/ZA985709B/xx unknown
- 1998-06-30 TN TNTNSN98123A patent/TNSN98123A1/fr unknown
- 1998-06-30 MA MA25145A patent/MA24586A1/fr unknown
- 1998-06-30 DZ DZ980154A patent/DZ2544A1/fr active
- 1998-07-01 HR HR980378A patent/HRP980378B1/xx not_active IP Right Cessation
- 1998-07-01 CO CO98037136A patent/CO4940405A1/es unknown
1999
- 1999-11-23 IS IS5266A patent/IS5266A/is unknown
- 1999-11-23 BG BG103917A patent/BG103917A/bg unknown
- 1999-12-23 OA OA9900306A patent/OA11246A/en unknown
- 1999-12-27 NO NO996492A patent/NO996492L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CO4940405A1 (es)	2000-07-24
CA2290973C (fr)	2003-06-17
TR199903282T2 (xx)	2000-08-21
HUP0002250A3 (en)	2001-01-29
EA199900963A1 (ru)	2000-08-28
NO996492D0 (no)	1999-12-27
KR100371730B1 (ko)	2003-02-07
ZA985709B (en)	2000-01-10
ID24673A (id)	2000-07-27
PT980241E (pt)	2004-03-31
EP0980241A1 (fr)	2000-02-23
AU7545098A (en)	1999-01-25
IL133075A0 (en)	2001-03-19
SK180599A3 (en)	2001-01-18
NZ501252A (en)	2004-11-26
WO1999001113A1 (fr)	1999-01-14
IS5266A (is)	1999-11-23
PL337807A1 (en)	2000-09-11
JP3585245B2 (ja)	2004-11-04
BR9809712A (pt)	2000-07-11
AP945A (en)	2001-02-28
HRP980378B1 (en)	2001-12-31
ES2210760T3 (es)	2004-07-01
ATE256457T1 (de)	2004-01-15
UA68350C2 (en)	2004-08-16
PA8454001A1 (es)	2000-05-24
GT199800090A (es)	1999-12-21
TNSN98123A1 (fr)	2005-03-15
KR20010013588A (fr)	2001-02-26
TW382597B (en)	2000-02-21
CN1261792A (zh)	2000-08-02
OA11246A (en)	2002-11-19
AR015916A1 (es)	2001-05-30
AU724635B2 (en)	2000-09-28
DK0980241T3 (da)	2004-04-05
BG103917A (bg)	2000-07-31
PE97299A1 (es)	1999-10-13
MA24586A1 (fr)	1998-12-31
AP9801279A0 (en)	1998-06-30
DE69820608D1 (de)	2004-01-29
EA001905B1 (ru)	2001-10-22
SK282914B6 (sk)	2003-01-09
NO996492L (no)	2000-02-29
HUP0002250A2 (hu)	2000-12-28
DE69820608T2 (de)	2004-12-23
MY119728A (en)	2005-07-29
HRP980378A2 (en)	1999-04-30
JP2000512316A (ja)	2000-09-19
EP0980241B1 (fr)	2003-12-17
UY25070A1 (es)	2000-12-29
CA2290973A1 (fr)	1999-01-14

Similar Documents

Publication	Publication Date	Title
DZ2546A1 (fr)	2003-02-08	Sels de sertraline et formes posologiques de sertraline à libération prolongée et procédé pour leur préparation.
DZ2923A1 (fr)	2004-03-01	Formulations pharmaceutiques d'inhibiteurs de pde-5 de gmpc à libération contrôlée, et procédé pour leur préparation.
MA26536A1 (fr)	2004-12-20	Association de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation.
DZ2186A1 (fr)	2002-12-02	Compositions pharmaceutiques mixtes pour le traitement de l'ostéoporose et procédé pour leur préparation.
DZ2600A1 (fr)	2003-03-01	Associations pharmaceutiques d'amlodipine et d'unestatine et procédé pour leur préparation.
DZ2523A1 (fr)	2003-02-01	Formulations pharmaceutiques contenant du voriconazole et procédé pour leur préparation.
DZ2634A1 (fr)	2003-03-08	Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant.
EG23978A (fr)	2008-02-26	Composition pharmaceutique de, benofibrate presentant une biodisponibilite elevee et son procede de preparation
DZ2197A1 (fr)	2002-12-02	Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2358A1 (fr)	2002-12-28	Amides inhibiteurs de sécrétion de apo b/mtp procédé pour leur préparation et compositions pharmaceutiques les contenant
FR2722984B1 (fr)	1996-10-18	Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
DZ2045A1 (fr)	2002-07-21	Amides thérapeutiques, procédé pour leur préparation et compositions les contenant.
EP0752405A3 (fr)	1997-03-26	Procédé pour la préparation de phénol
EP0761718A3 (fr)	1997-05-02	Procédé pour la préparation de poly-o-hydroxyamides et de poly-o-mercaptoamides
FR2702660B1 (fr)	1995-05-24	Compositions thérapeutiques stabilisées et leur procédé de préparation.
DZ1946A1 (fr)	2002-02-17	Procédé pour la préparation de supports.
DZ2309A1 (fr)	2002-12-28	Dérivés de pyrrolidinyl-et pyrrolinyl-éthylamine procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2720397B1 (fr)	1996-08-23	Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.
DZ2658A1 (fr)	2003-03-22	Formulations nouvelles de paroxétine et procédé pour leur préparation.
MA24586A1 (fr)	1998-12-31	Formes posologiques de sertraline et procede par leur preparation.
MA23663A1 (fr)	1996-04-01	Procede de preparation de formulations pharmaceutiques
EP0659779A3 (fr)	1996-05-22	Microsphères et procédé de leur préparation.
EP0761721A3 (fr)	1997-05-02	Procédé pour la préparation de poly-o-hydroxyamides et de poly-o-mercaptoamides
DZ2976A1 (fr)	2004-03-15	Inhibiteurs de protéases nouveaux, procédé pour leur préparation et compositions pharmaceutiques lescontenant.
DZ2913A1 (fr)	2004-03-01	Composition pharmaceutique concentrée liquide de sertraline et procédé pour sa préparation.